The C-terminal tetrapeptide of β-endorphin (MPF) enhances lymphocyte proliferative responses

Neuropeptides

Volumn 32, Issue 2, 1998, Pages 131-139

  Owen, D L ^a   Morley, J S ^b   Ensor, D M ^a   Miles, J B ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Fazakerley   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; LEUCINE ENKEPHALIN; METENKEPHALIN; TETRAPEPTIDE;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALIA;

EID: 0031925080     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(98)90028-2     Document Type: Article

References (29)

1. Ader R, Cohen N, Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 1995; 345: 99-103.
2. Morley J E, Kay N E, Solomon G F, Plotnikoff N P. Neuropeptides: conductors of the immune orchestra. Life Sci 1987; 41: 527-544.
3. Sibinga N E S, Goldstein A. Opioid peptides and opioid receptors in cells of the immune system. Annu Rev Immunol 1988; 6: 219-249.
4. Lyons P D, Blalock J E. Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J Neuroimmunology 1997; 47-56.
5. Smith E M, Galin F S, LeBoeuf R D, Coppenhaver D H, Harbour D V, Blalock J E. Nucleotide and amino acid sequence of lymphocyte-derived corticotropin: endotaxin induction of a truncated peptide. Proc Natl Acad Sci USA 1990; 87: 1057-1060.
6. Lolait S J, Clements J A, Markwick A J et al. Proopiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. J Clin Invest 1986; 77: 1776-1179.
7. Heijnen C J, Kavelaars A, Ballieux R E. β-endorphin: cytokine and neuropeptide. Immunol Rev 1991; 119: 41-63.
8. Carter R J, Shuster S, Morley J S. Melanotropin potentiating factor is the C-terminal tetrapeptide of human β-lipotropin. Nature 1979; 279: 74.
9. Wybran D A, Appleboom T, Famaey J P, Govaerts A. Suggestive evidence for receptors for morphine and methionineenkephalin on normal blood T-lymphocytes. J Immunol 1979; 123: 1068-1070.
10. Bessler H, Sztein M B, Serrate S A. β-endorphin modulation of IL-1 induced IL-2 production. Immunopharmacology 1990; 19: 4-14.
11. Peterson P K, Sharp B M, Gekker G, Brummitt C, Keane W F. Opiate mediated suppression of interferon-γ production by cultured peripheral blood mononuclear cells. J Clin Invest 1987; 80: 824-831.
12. Gilman S J, Schwartz J M, Milner R J, Bloom F E, Feldman J D. γ-Endorphin enhances lymphocyte proliferative responses. Proc Natl Acad Sci USA 1982; 79: 4226-4230.
13. Shahabi N A, Burtness M Z, Sharp B M. N-Acetyl β-endorphin 1-31 antagonizes the suppressive effect of β-endorphin 1-31 on murine splenocyte proliferation via a naloxone-resistant receptor. Biochem Biophys Res Commun 1991; 175: 936-942.
14. Gilmore W, Weiner L P. The opioid specificity of beta-endorphin enhancement of murine lymphocyte proliferation. Immunopharmacology 1989; 17: 19-30.
15. McCain H W, Lamster I B, Bozzone J M, Grbic J T. β-endorphin modulates human immune activity via non-opiate receptor mechanisms. Life Sci 1982; 31: 1619-1624.
16. Heijnen C J, Zijlstra J, Kavelaars A, Croiset G, Ballieux R E. Modulation of the immune response by PMOC-derived peptides: I. Influence on proliferation of human lymphocytes. Brain Behav Immun 1987; 1: 284.
17. Hemmick L M, Bidlack J M. β-Endorphin modulation of mitogen-stimulated calcium uptake by rat thymocytes. Life Sci 1987; 41: 1971-1978.
18. Hazum E, Chang K-J, Cuatrecasas P. Specific non-opiate receptors for β-endorphin. Science 1979; 205: 1033-1035.
19. Shahabi N A, Bost K L, Madhok T C, Sharp B M. Characterisation of antisera to the naloxone-insensitive receptor for β-endorphin on U937 cells generated by using the complementary peptide strategy. J Pharmacol Exp Ther 1992; 263: 876-883.
20. Owen D B, Morley J S, Ensor D M, Allen Y, Miles J B. Trophic effects of melanotropin potentiating factor (MPF) on cultures of cells of the central nervous system. Peptides 1997 18: 1015-1021.
21. Ensor D M, Morley J S, Redfern R M, Miles J B. Stimulation of dopamine output from adrenal medullary cells by β-endorphin and its C-terminal tetrapeptide (MPF). Brain Res 1989; 490: 196-199.
22. Morley J S, Ensor D M. Neurotrophic effects of beta endorphin C-terminal tetrapeptide (MPF). Neuropeptides 1986; 8: 45-49.
23. Ensor D M, Morley J S, Redfern R M, Miles J B. The activity of an analogue of MPF (β-endorphin 28-31) in a rat model of Parkinson's disease. Brain Res 1993; 610: 166-168.
24. Morley J S, Bazzaz A A, Ensor D M, Miles J B. Reversal of mitochondrial damage in a rat model of Parkinson's disease by a neurotrophic peptide (MPF analogue). NeuroReports 1994; 5: 1877-1881.
25. Morley J S, Hayward C F, Carter RJ, Shuster S. MPF analogue with stability to proteolysis. Neuropeptides 1981; 2: 109-114.
26. Morley J S, Ensor D M. Structural specificity of beta-endorphin C-terminal tetrapeptide (MPF) in promoting urodele limb regeneration. Life Sci 1989; 45: 1341-1347
27. Greaves M F, Bauminger S. Activation of T and B lymphocytes by insoluble phytomitogens. Nature (New Biol) 1972; 235: 67-70.
28. Schweigerer L, Bhakdi S, Teschemacher H. Specific non-opiate binding sites for human β-endorphin on the terminal complex of human complement. Nature 1982; 296: 572-574.
29. Schweigerer L, Teschemacher H, Bhakdi S, Lederle M. Interaction of human β-endorphin with nonopiate binding sites on the terminal SC5b-9 complex of human complement. J Biol Chem 1983; 258: 12287-12292.